A double-blind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea.
D000328:Adult; D002986:Clinical Trials as Topic; D004200:Diseases in Twins / Q000188:drug therapy*; D004298:Dopamine / Q000378:metabolism; D004341:Drug Evaluation; D005260:Female; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006816:Huntington Disease / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009461:Neurologic Manifestations; D009497:Neurotic Disorders / Q000139:chemically induced; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010640:Phenothiazines / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D010919:Placebos; D012701:Serotonin / Q000378:metabolism; D013747:Tetrabenazine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*
D010640:Phenothiazines; D010919:Placebos; D012701:Serotonin; D004298:Dopamine; D006719:Homovanillic Acid; D013747:Tetrabenazine